tortoiseshell Clubmaster-style sunglasses near beaded brown necklace

Photo by S O C I A L . C U T on Unsplash

Neiman Marcus Parts Ways With Luxury Online Retailer Farfetch

February 7, 2024

Neiman Marcus Group has decided to terminate its commercial partnership with online luxury retailer Farfetch. This move shakes up the dynamic between the two companies, each a major player in their respective domains. Neiman Marcus primarily operates in physical retail spaces, while Farfetch is a digital-first luxury platform.

The alliance between Neiman Marcus and Farfetch took form roughly two years ago. At that time, Farfetch was flying high and invested a hefty sum of $200 million in Neiman Marcus. In return, Farfetch received a minority stake in the iconic American luxury department store chain.

The collaboration reached further depths when Farfetch took over the web presence of Bergdorf Goodman, a subsidiary of Neiman Marcus. Farfetch overhauled Bergdorf Goodman’s website and mobile application, giving the brand an enhanced digital platform. Meanwhile, Neiman Marcus and Bergdorf Goodman became part of Farfetch’s expansive online marketplace, joining as partners.


However, this partnership was not destined to last forever. Farfetch has recently been experiencing financial difficulties, forcing it to seek rescue funds. The company received a significant lifeline in the form of a $500 million investment from South Korea’s Coupang and U.S.-based investment firm Greenoaks.

Neiman Marcus has clarified its stance on the partnership dissolution. The luxury retail group stated that the Bergdorf Goodman website and app would continue to operate independently, catering to its customers’ luxury e-commerce needs. The digital platforms will no longer be under Farfetch’s umbrella.

Interestingly, Farfetch will not sever all ties with Neiman Marcus. Despite the end of their commercial partnership, Farfetch will remain as a minority, non-voting investor in the American department store. This arrangement emphasizes the unexpected nature of the retail industry, where alliances can quickly shift and business strategies can take unexpected turns. It remains to be seen how this change will impact both companies in the long run.


Recent News

Massive Data Breach Hits Ticketmaster, Affecting 560 Million Customers

Ticketmaster has fallen victim to a significant cyber-attack, potentially compromising the data of up to 560 million customers. The breach was confirmed by Ticketmaster’s parent company, Live Nation, which revealed that a notorious hacking group, ShinyHunters, is behind the attack. The hackers are demanding a ransom of approximately £400,000 to prevent the data from being sold on the dark web.

Toyota Recalls 100,000+ Tundra and Lexus LX SUVs Over Engine Debris Issue

Toyota has announced a recall for over 100,000 Tundra pickups and Lexus LX SUVs in North America due to potential engine issues caused by machining debris. This recall affects certain 2022-2023 models of the Tundra and LX, which are equipped with the new V6 twin-turbo engine. The V6 twin-turbo engine has faced considerable scrutiny regarding its reliability, especially when compared to the previous naturally aspirated V8 engines.

Wordle and Worldle Battle Over Names

A legal dispute has erupted between the wildly popular word game Wordle and the lesser-known geography game Worldle, centering on the similarity of their names. Wordle, which was developed by Josh Wardle in 2021 and later acquired by the New York Times in 2022 for a substantial sum, has gained immense popularity. In this game, players have six attempts to guess a five-letter word. 

FDA Issues Recall for Crecelac Goat Milk Infant Formula

The U.S. Food and Drug Administration (FDA) has issued a safety alert regarding Crecelac Goat Milk Infant Formula and other infant formula products imported and distributed by Dairy Manufacturers Inc. The alert highlights Cronobacter contamination concerns with Crecelac Infant Powdered Goat Milk Infant Formula. Although Dairy Manufacturers Inc. initiated a recall on May 24, 2024, due to non-compliance with FDA regulations, new findings of Cronobacter contamination have prompted further action.